PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1251573
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1251573
Global Targeted Sequencing and Resequencing Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 22.59% over the forecast period 2022-2029. Targeted Sequencing is a method of detecting unusual variants in a certain set of genes whereas, Resequencing is a method in which a subset of genes is isolated and sequenced. Targeted Sequencing and Resequencing are the methods used for the sequencing of a portion of a person's genome to look for sequence discrepancies between that person and the species' typical genome. Shotgun and high throughput are the two main types of DNA sequencing. Targeted sequencing and resequencing are used for the detection of mutations in DNA caused by various congenital diseases. In comparison to WGS and other survey methods, it provides a proper analysis of the results and prevents the erroneous interpretation of sequencing data. Cost-saving advantages of full genome sequencing, increasing R&D investments in the pharmaceutical industry, advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology are the factors driving the major market growth.
According to the National Library of Medicine, full genome sequencing costs about $10 million in 2007. Since then, sequencing prices have decreased rapidly, and it is expected that the $1000 genome will soon become a reality. Additionally, in 2019, R&D expenditures in the pharmaceutical business were $83 billion. Particularly, between 2015 and 2019, investment in pharmaceutical R&D surged by about 50%. Increasing R&D investments leads to the development of innovative Sequencing and Resequencing techniques. Cost-saving advantages of full genome sequencing and increasing research and development investments in the pharmaceutical industry are the major factors driving the growth of the market. Other components driving market increase are the advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology. Furthermore, emerging digital next-generation sequencing technology and advancements to perform sequencing in less time are the factors creating major market opportunities in the forecast period. However, the high cost of maintaining Targeted Sequencing and Resequencing stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Targeted Sequencing And Resequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of market players, increasing advancements in technology, and the region's increasing development of sequencing capabilities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing investments in research & development, the prevalence of advanced technology for drug development and discovery, and the geographic expansion of key players.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable